These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38922537)

  • 1. Shifting cold to hot tumors by nanoparticle-loaded drugs and products.
    Ahmad I; Altameemi KKA; Hani MM; Ali AM; Shareef HK; Hassan ZF; Alubiady MHS; Al-Abdeen SHZ; Shakier HG; Redhee AH
    Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38922537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Igniting Hope for Tumor Immunotherapy: Promoting the "Hot and Cold" Tumor Transition.
    Wei C; Ma Y; Wang F; Liao Y; Chen Y; Zhao B; Zhao Q; Wang D; Tang D
    Clin Med Insights Oncol; 2022; 16():11795549221120708. PubMed ID: 36147198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy.
    Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D
    Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic tumor microenvironment modulators for turning cold tumors hot.
    Khosravi GR; Mostafavi S; Bastan S; Ebrahimi N; Gharibvand RS; Eskandari N
    Cancer Commun (Lond); 2024 May; 44(5):521-553. PubMed ID: 38551889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants.
    Gao F; You X; Yang L; Zou X; Sui B
    Int Rev Immunol; 2024; 43(5):280-308. PubMed ID: 38525925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
    Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
    Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of adenosine on adaptive antitumor immunity and intervention strategies.
    Wang L; Zhang W; Zhang J; Zheng M; Pan X; Guo H; Ding L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 52(5):567-577. PubMed ID: 37916308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
    Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
    Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Treatment Strategies Targeting the Tumor Microenvironment: How to Convert "Cold" Tumors to "Hot" Tumors.
    Yang L; Hu Q; Huang T
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy.
    Lu Q; Kou D; Lou S; Ashrafizadeh M; Aref AR; Canadas I; Tian Y; Niu X; Wang Y; Torabian P; Wang L; Sethi G; Tergaonkar V; Tay F; Yuan Z; Han P
    J Hematol Oncol; 2024 Apr; 17(1):16. PubMed ID: 38566199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.
    Han Y; Tian X; Zhai J; Zhang Z
    Front Cell Dev Biol; 2024; 12():1363121. PubMed ID: 38774648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and exploration for immunotherapies targeting cold colorectal cancer.
    Li DD; Tang YL; Wang X
    World J Gastrointest Oncol; 2023 Jan; 15(1):55-68. PubMed ID: 36684057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
    Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
    Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.
    Seclì L; Infante L; Nocchi L; De Lucia M; Cotugno G; Leoni G; Micarelli E; Garzia I; Avalle L; Sdruscia G; Troise F; Allocca S; Romano G; Scarselli E; D'Alise AM
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Nanophotoimmunotherapy Potentiates Cancer Treatment by Enhancing Tumor Immunogenicity and Improving the Immunosuppressive Tumor Microenvironment.
    Li K; Yang D; Liu D
    Bioconjug Chem; 2023 Feb; 34(2):283-301. PubMed ID: 36648963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles.
    Rodallec A; Sicard G; Fanciullino R; Benzekry S; Lacarelle B; Milano G; Ciccolini J
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1139-1147. PubMed ID: 30354685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.
    Huang M; Cha Z; Liu R; Lin M; Gafoor NA; Kong T; Ge F; Chen W
    Front Immunol; 2024; 15():1399926. PubMed ID: 38817608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.